Last reviewed · How we verify

A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of Glycopyrronium in Subjects With Axillary Hyperhydrosis

NCT02530281 Phase 3 COMPLETED Results posted

The study is a randomized, double-blind, vehicle controlled, parallel group study, designed to assess the efficacy and safety of glycopyrronium topical wipes, once daily, compared to vehicle in subjects with axillary hyperhidrosis.

Details

Lead sponsorJourney Medical Corporation
PhasePhase 3
StatusCOMPLETED
Enrolment344
Start date2015-07
Completion2016-03

Conditions

Interventions

Primary outcomes

Countries

United States, Germany